cytomed.sg - Home

Example domain paragraphs

Menu Home About About Us Our Team Publications Platform CAR-γδ T Cell iPSC-γδ NKT Cell Pipeline Manufacturer Investors Contact Us Make An Appointment Advancing "Off-the-shelf” Allogeneic Cellular Immunotherapy for a Broad-spectrum of Cancers Pioneering Stem Cell Research & Therapy Contact Us Seek, See and Destroy ‒ iPSC-γδ NKT Cells Eliminate Cancer Cells! CytoMed's Technologies

CytoMed is translating its patent-pending technologies into gamma delta (γδ) T cell- and natural killer (NK) cell-based "off-the-shelf" immunotherapeutics for a wide range of cancers.

CytoMed also engages in generating induced pluripotent stem cells (iPSCs) and developing them into cellular therapeutics using our proprietary technologies for our customers.

Links to cytomed.sg (2)